-
Je něco špatně v tomto záznamu ?
MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells
Lubica Ondrušová, Jiri Vachtenheim, Jiri Réda, Petra Žáková, Kamila Benková
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT11229
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Directory of Open Access Journals
od 2006
Free Medical Journals
od 2006
Public Library of Science (PLoS)
od 2006
PubMed Central
od 2006
Europe PubMed Central
od 2006
ProQuest Central
od 2006-12-01
Open Access Digital Library
od 2006-10-01
Open Access Digital Library
od 2006-01-01
Open Access Digital Library
od 2006-01-01
Medline Complete (EBSCOhost)
od 2008-01-01
Nursing & Allied Health Database (ProQuest)
od 2006-12-01
Health & Medicine (ProQuest)
od 2006-12-01
Public Health Database (ProQuest)
od 2006-12-01
ROAD: Directory of Open Access Scholarly Resources
od 2006
- MeSH
- apoptóza genetika MeSH
- chromozomální proteiny, nehistonové genetika metabolismus MeSH
- cyklin-dependentní kinasa 2 genetika metabolismus MeSH
- DNA-helikasy genetika metabolismus MeSH
- imunohistochemie MeSH
- inhibitory apoptózy genetika metabolismus MeSH
- insulinu podobný růstový faktor I genetika metabolismus MeSH
- jaderné proteiny genetika metabolismus MeSH
- lidé MeSH
- melanom genetika metabolismus patologie MeSH
- nádorové buněčné linie MeSH
- névus genetika metabolismus patologie MeSH
- osteopontin genetika metabolismus MeSH
- polymerázová řetězová reakce s reverzní transkripcí MeSH
- proliferace buněk MeSH
- RNA interference MeSH
- sekvenční analýza hybridizací s uspořádaným souborem oligonukleotidů MeSH
- stanovení celkové genové exprese MeSH
- transformující růstový faktor beta2 genetika metabolismus MeSH
- transkripční faktor spojený s mikroftalmií genetika metabolismus MeSH
- transkripční faktory genetika metabolismus MeSH
- viabilita buněk genetika MeSH
- western blotting MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Metastasized malignant melanoma has a poor prognosis because of its intrinsic resistance to chemotherapy and radiotherapy. The central role in the melanoma transcriptional network has the transcription factor MITF (microphthalmia-associated transcription factor). It has been shown recently that the expression of MITF and some of its target genes require the SWI/SNF chromatin remodeling complex. Here we demonstrate that survival of melanoma cells requires functional SWI/SNF complex not only by supporting expression of MITF and its targets and but also by activating expression of prosurvival proteins not directly regulated by MITF. Microarray analysis revealed that besides the MITF-driven genes, expression of proteins like osteopontin, IGF1, TGFß2 and survivin, the factors known to be generally associated with progression of tumors and the antiapoptotic properties, were reduced in acute BRG1-depleted 501mel cells. Western blots and RT-PCR confirmed the microarray findings. These proteins have been verified to be expressed independently of MITF, because MITF depletion did not impair their expression. Because these genes are not regulated by MITF, the data suggests that loss of BRG1-based SWI/SNF complexes negatively affects survival pathways beyond the MITF cascade. Immunohistochemistry showed high expression of both BRM and BRG1 in primary melanomas. Exogenous CDK2, osteopontin, or IGF1 each alone partly relieved the block of proliferation imposed by BRG1 depletion, implicating that more factors, besides the MITF target genes, are involved in melanoma cell survival. Together these results demonstrate an essential role of SWI/SNF for the expression of MITF-dependent and MITF-independent prosurvival factors in melanoma cells and suggest that SWI/SNF may be a potential and effective target in melanoma therapy.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13031682
- 003
- CZ-PrNML
- 005
- 20141223084714.0
- 007
- ta
- 008
- 131002s2013 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.pone.0054110 $2 doi
- 035 __
- $a (PubMed)23349796
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Ondrušová, Lubica $u Laboratory of Transcription and Cell Signaling, Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 245 10
- $a MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells / $c Lubica Ondrušová, Jiri Vachtenheim, Jiri Réda, Petra Žáková, Kamila Benková
- 520 9_
- $a Metastasized malignant melanoma has a poor prognosis because of its intrinsic resistance to chemotherapy and radiotherapy. The central role in the melanoma transcriptional network has the transcription factor MITF (microphthalmia-associated transcription factor). It has been shown recently that the expression of MITF and some of its target genes require the SWI/SNF chromatin remodeling complex. Here we demonstrate that survival of melanoma cells requires functional SWI/SNF complex not only by supporting expression of MITF and its targets and but also by activating expression of prosurvival proteins not directly regulated by MITF. Microarray analysis revealed that besides the MITF-driven genes, expression of proteins like osteopontin, IGF1, TGFß2 and survivin, the factors known to be generally associated with progression of tumors and the antiapoptotic properties, were reduced in acute BRG1-depleted 501mel cells. Western blots and RT-PCR confirmed the microarray findings. These proteins have been verified to be expressed independently of MITF, because MITF depletion did not impair their expression. Because these genes are not regulated by MITF, the data suggests that loss of BRG1-based SWI/SNF complexes negatively affects survival pathways beyond the MITF cascade. Immunohistochemistry showed high expression of both BRM and BRG1 in primary melanomas. Exogenous CDK2, osteopontin, or IGF1 each alone partly relieved the block of proliferation imposed by BRG1 depletion, implicating that more factors, besides the MITF target genes, are involved in melanoma cell survival. Together these results demonstrate an essential role of SWI/SNF for the expression of MITF-dependent and MITF-independent prosurvival factors in melanoma cells and suggest that SWI/SNF may be a potential and effective target in melanoma therapy.
- 650 _2
- $a apoptóza $x genetika $7 D017209
- 650 _2
- $a western blotting $7 D015153
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a proliferace buněk $7 D049109
- 650 _2
- $a viabilita buněk $x genetika $7 D002470
- 650 _2
- $a chromozomální proteiny, nehistonové $x genetika $x metabolismus $7 D002868
- 650 _2
- $a cyklin-dependentní kinasa 2 $x genetika $x metabolismus $7 D051357
- 650 _2
- $a DNA-helikasy $x genetika $x metabolismus $7 D004265
- 650 _2
- $a stanovení celkové genové exprese $7 D020869
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a inhibitory apoptózy $x genetika $x metabolismus $7 D051034
- 650 _2
- $a insulinu podobný růstový faktor I $x genetika $x metabolismus $7 D007334
- 650 _2
- $a melanom $x genetika $x metabolismus $x patologie $7 D008545
- 650 _2
- $a transkripční faktor spojený s mikroftalmií $x genetika $x metabolismus $7 D051739
- 650 _2
- $a névus $x genetika $x metabolismus $x patologie $7 D009506
- 650 _2
- $a jaderné proteiny $x genetika $x metabolismus $7 D009687
- 650 _2
- $a sekvenční analýza hybridizací s uspořádaným souborem oligonukleotidů $7 D020411
- 650 _2
- $a osteopontin $x genetika $x metabolismus $7 D053495
- 650 _2
- $a RNA interference $7 D034622
- 650 _2
- $a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
- 650 _2
- $a transkripční faktory $x genetika $x metabolismus $7 D014157
- 650 _2
- $a transformující růstový faktor beta2 $x genetika $x metabolismus $7 D053781
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vachtenheim, Jiri $u Laboratory of Transcription and Cell Signaling, Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Réda, Jiri $u Laboratory of Transcription and Cell Signaling, Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Záková, Petra $u Laboratory of Transcription and Cell Signaling, Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Benková, Kamila $u Department of Pathology, Hospital Bulovka, Prague, Czech Republic
- 773 0_
- $w MED00180950 $t PloS one $x 1932-6203 $g Roč. 8, č. 1 (2013), s. e54110
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23349796 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20131002 $b ABA008
- 991 __
- $a 20141223084737 $b ABA008
- 999 __
- $a ok $b bmc $g 995769 $s 830127
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 8 $c 1 $d e54110 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
- GRA __
- $a NT11229 $p MZ0
- LZP __
- $a Pubmed-20131002